Keywords: epoetin; hepcidin; hypoxia-inducible factor; HIF activators;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Biopharmaceutical; Biosimilar; Darbepoetin alfa; Epoetin; Glycan; Glycomic characterization; Glycopeptide; Glycosylation; Mass spectrometry; Recombinant erythropoietin;
Keywords: chemotherapy-induced anemia; darbepoetin; epoetin; erythropoiesis-stimulating agent;
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
Keywords: anemia of chronic kidney disease; daprodustat; epoetin; erythropoiesis-stimulating agents; ESA hyporesponsiveness; hemodialysis;
The Emerging Role of Biosimilar Epoetins in Nephrology in the United States
Keywords: Biologic; biosimilar; bioequivalent drug; epoetin; epoetin alfa; epoetin zeta; recombinant human erythropoietin (rHuEPO); erythropoiesis-stimulating agent (ESA); anemia; chronic kidney disease (CKD); economics; safety; Retacrit;
A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
Keywords: Anemia; chronic kidney disease (CKD); darbepoetin; drug sensitivity; epoetin; erythropoiesis-stimulating agent (ESA); ESA hyporesponsiveness; ESA resistance index (ERI); erythropoietin; pentoxifylline; hemoglobin; dialysis; randomized controlled trial;
A Safe and Easy Introduction of Darbepoetin-Alpha in Patients Receiving Maintenance Hemodialysis and Epoetin Monotherapy: A “Half-and-Half” Combination Therapy
Keywords: combination therapy; darbepoetin; epoetin; hemodialysis patients
Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis
Keywords: EPO; Epoetin; Darbepoetin; Haemodialysis; Lectin chromatography; WGA
Clinical and Economic Evaluation of an Evidence-Based Institutional Epoetin-Utilization Management Program
Keywords: cost; clinical pharmacy; drug-utilization evaluation; epoetin; erythropoietin-stimulating agent
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Keywords: Erythropoietin; erythropoiesis-stimulating agent (ESA); epoetin; darbepoetin; anemia; chronic kidney disease (CKD); dose; mortality; cardiovascular morbidity; metaregression;
The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial
Keywords: anemia; epoetin; hemodialysis; quality of life;
High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes
Keywords: cardiovascular outcomes; diabetes; epoetin; hemodialysis; marginal structural modeling; mortality
Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease
Keywords: cardiovascular events; chronic kidney disease; epidemiology and outcomes; epoetin
Therapy with Erythropoiesis-Stimulating Agents and Renal and Nonrenal Outcomes
Keywords: Epoetin; Epogen; Erythropoiesis-stimulating agents; CKD; ESRD;
Recommandations d’utilisation des biosimilaires de l’érythropoïétine (EPO). Propositions de la Société de néphrologie, de la Société francophone de dialyse et de la Société de néphrologie pédiatrique
Keywords: Recommandation; Époétines; BiosimilairesPosition statement; Biosimilars; Epoetin
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
Keywords: Anaemia; Breast cancer; Epoetin; Thrombovascular events
Anemia Management and Association of Race With Mortality and Hospitalization in a Large Not-for-Profit Dialysis Organization
Keywords: Epoetin; hemoglobin; mortality; hospitalization; hemodialysis;
Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications
Keywords: Anemia; Renal; ESAs; Erythropoietin; Epoetin; Iron;
Diagnosis and Treatment of Anemia of Chronic Kidney Disease in the Primary Care Setting: A Primer for Nurse Practitioners
Keywords: Anemia; chronic kidney disease; darbepoetin; epoetin; ESAs (erythropoiesis-stimulating agents); predialysis
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation
Keywords: cost effectiveness analysis; end stage renal disease; hemodialysis; treatment costs; sodium ferric gluconate complex; epoetin
Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer
Keywords: Ovarian cancer; Peritoneal cancer; Anemia; Epoetin; Darbepoetin; Chemotherapy
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants
Keywords: anemia; epoetin; hemoglobin; K/DOQI guidelines; renal dialysis; renal transplant
Immunogenicity of therapeutic proteins. Part 2: Impact of container closures
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Container closures; Epoetin; PRCA
Immunogenicity of therapeutic proteins. Part 3: Impact of manufacturing changes
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Manufacturing changes; Epoetin; PRCA
Immunogenicity of therapeutic proteins. Part 1: Impact of product handling
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Neutralizing antibody; Epoetin; PRCA
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation
Keywords: reticulocyte hemoglobin content; ferric gluconate; ferritin; response predictors; transferrin saturation; epoetin
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: Applying ispor task force guidelines on methodological quality of retrospective studies
Keywords: Epoetin; Guidelines; Poster; Methodology; Database
Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia
Keywords: Erythropoietin; Erythropoietin receptors; Epoetin; Preclinical drug evaluation; In vitro; Neoplasms; Mortality
Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial
Keywords: Chronic kidney disease; continuous erythropoietin receptor activator; C.E.R.A.; epoetin; hemoglobin; renal anemia; anemia correction; methoxy polyethylene glycol-epoetin beta;
Règles d'utilisation des biosimilaires
Keywords: Recommandation; Ãpoétines; Biosimilaires; Guidelines; Epoetin; Biosimilars;
Recent Advances in Erythropoietic Agents in Renal Anemia
Keywords: novel erythropoietic agents; anaemia; epoetin; darbepoetin alfa; biosimilars; CERA; Hematide; HIF stabilisers
Anemia in the Kidney-Transplant Patient
Keywords: Anemia; epoetin; iron deficiency; kidney transplantation;
Estudio de utilización y descripción de costes de eritropoyetina en pacientes hematológicos
Keywords: Eritropoyetina; Epoetina; HematologÃa; Efectividad; Coste; Erythropoietin; Epoetin; Hematology; Effectiveness; Cost;
Clinical characteristics of erythropoietin-associated pure red cell aplasia
Keywords: PRCA; epoetin; autoantibodies;
Body Fat Mass and Serum Leptin Levels Influence Epoetin Sensitivity in Patients With ESRD
Keywords: Renal anemia; epoetin; inflammation; leptin; fat mass; chronic renal failure; end-stage renal disease (ESRD);
Importance of biologic follow-ons: experience with EPO
Keywords: epoetin; pure red cell aplasia; chronic kidney disease;
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group
Keywords: pure red cell aplasia (PRCA); erythropoietin; epoetin; adverse events;
Iron requirements in erythropoietin therapy
Keywords: erythropoietin; epoetin; anemia; iron therapy; functional iron deficiency; safety of intravenous iron;